ResearcherActive in the last 2 years

Peng Ning

Provisional: name only (low confidence)As of 11 November 2026

Known by name only; no external author ID or institution yet. Name as it appears in OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2024: 1 paper

Papers 1

Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study. Last author DOI 10.3389/fonc.2024.1370009 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Jie Yang · 1 shared paper, 2024
- Paper Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a populatio… DOI 10.3389/fonc.2024.1370009 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.